Humacyte to Present at the Jefferies Healthcare Conference
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), Humacyte, Inc. (Nasdaq:…
Month: June 2023
Humacyte to Present at the Jefferies Healthcare Conference
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), Humacyte, Inc. (Nasdaq:…
PolyPid Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement and Transfer of its Listing to the Nasdaq Capital Market
PETACH TIKVA, Israel, June 05, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”),…
PolyPid Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement and Transfer of its Listing to the Nasdaq Capital Market
PETACH TIKVA, Israel, June 05, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”),…
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
Erasca Provides Update on Clinical Program for ERK Inhibitor ERAS-007 and Refines Pipeline
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC…
Erasca Provides Update on Clinical Program for ERK Inhibitor ERAS-007 and Refines Pipeline
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC…
Ocular Therapeutix™ To Present 12-Month Top-Line Data from U.S.-Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company…
Ocular Therapeutix™ To Present 12-Month Top-Line Data from U.S.-Based Phase 1 Clinical Trial of OTX-TKI in Wet Age-Related Macular Degeneration at the 2023 Clinical Trials at the Summit Annual Meeting
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company…
Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares
Aggregate Gross Proceeds of $143.7 Million from Public Offering and Private Placement THE WOODLANDS, Texas,…
Westinghouse Announces New President of eVinci™ Microreactor Business
Experienced Nuclear Leader Jon Ball Named to Lead Next Phase of Global Deployment CRANBERRY TOWNSHIP,…
Hillcrest Announces Effective Date of Share Consolidation
Vancouver, British Columbia–(Newsfile Corp. – June 5, 2023) – Hillcrest Energy Technologies (CSE: HEAT) (OTCQB:…
Micromem Update on Projects in Romania
Toronto, Ontario and New York, New York–(Newsfile Corp. – June 5, 2023) – Micromem Technologies…
LeanTaaS Announces iQueue Autopilot, First Ever Generative AI Hospital Operations Solution
LeanTaaS’ unique combination of award-winning AI, the largest hospital operations dataset, and 100+ team of…
Keysight to Highlight Automotive Testing Innovations at ATE Europe 2023
–(BUSINESS WIRE)–$KEYS #ATE–Keysight Technologies, Inc. (NYSE: KEYS): What: The automotive industry is embracing new technologies…
J.P. Morgan Wealth Plan™ Recognized as Best Digital Initiative and Best Use of Technology
Banking Tech USA Awards Honored Wealth Plan for Expanding Access to Wealth Management NEW YORK–(BUSINESS…
VBA Announces New Solution That Will Drastically Speed up Processing of Healthcare Claims
GERMANTOWN, Wis.–(BUSINESS WIRE)–VBA, a leading technology company for healthcare payers, announced an innovation in its…